
SBLOF
Healthcare · Diagnostics & Research · $381.4M market cap
$9.160.00 (0.0%)Nov 13, 9:30 AM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Aug 3, 2025 | After the close | — | 0.04 | — |
| Feb 4, 2025 | After the close | — | 0.30 | — |
| Aug 5, 2024 | After the close | — | 0.02 | — |
| May 7, 2024 | After the close | — | 0.28 | — |
| Feb 1, 2024 | After the close | — | 0.13 | — |
Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, engages in the pharmaceutical development, transactional research, and medipolis businesses in Japan and internationally. It offers non-clinical testing and non-clinical regulatory consulting for the development of pharmaceuticals, medical devices, or regenerative medicine products, including safety and pharmacology testing, and…